Physician profile
John Lagrand
NPI 1972507911
$57,567.21
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47K · 2020: $9,718 · 2021: $576 · 2022: $347 · 2023: $317 · 2024: $97.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $414.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $54,192.84 | 2019-2020 | |
| Olympus America INC. | $2,441.00 | 2019-2024 | Olympus, Endoeye Flex Deflectable Videoscope |
| Minerva Surgical, INC | $268.28 | 2019-2022 | |
| Abbvie INC. | $179.74 | 2019-2023 | |
| Stryker Corporation | $146.55 | 2019-2022 | |
| Gynesonics, INC. | $76.80 | 2021-2022 | |
| Baxter Healthcare | $70.42 | 2023 | Floseal |
| Meditrina | $59.65 | 2023 | |
| Coopersurgical, INC. | $52.40 | 2019-2021 | |
| Exeltis, USA INC. | $20.45 | 2021 | |
| Therapeuticsmd, INC. | $17.11 | 2019 | |
| Acessa Health INC. | $15.11 | 2021 | |
| Allergan, INC. | $14.37 | 2019 | |
| Amag Pharmaceuticals, INC. | $12.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lagrand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.